Virtual Event

What is Qwoted?

Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.

Event Date Tue Feb 16 EST - Thu Feb 18 EST (8 months ago)
Location Virtual Event
Region All

For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.

The virtual 2021 event, taking place February 16-18, will showcase the Biotechnology Innovation Organization’s (BIO) perspective on the new U.S. Congressional agenda, the record setting pacing of biotech IPOs and the hottest clinical developments and industry catalysts.

Build on the momentum from JPM Week and experience the best of biotech with three-days of productive BIO One-on-One Partnering meetings with institutional investors, industry analysts, and senior business development executives seeking potential investments and deal partners.


2021 Speakers

Andrew Lo
Co-founder, Qls Advisors

Raymond Alvarez
CEO, Ichor Biologics

Phyllis Arthur
Vice President, Infectious Diseases and Diagnostics Policy, Biotechnology Innovation Organization

Martin Babler
Board Member, Neoleukin Therapeutics

Annette Bakker
President, Children's Tumor Foundation

Chris Baldwin
Chief Commercial Officer, Exopharm Ltd

Connor Barth
CEO, Inherent Targeting

Dror Bashan
President & CEO, Protalix Biotherapeutics

Jacob Bell
Senior Reporter, Biopharma Dive

Gil Beyen
CEO, Erytech Pharma

Abhijit Bhatia, Mba, Ms
Vice President of Global Corporate & Business Development, Rakuten Medical Japan K.k.

Greg Bosch, MBA
Chief Executive Officer, Geistlich Pharma North America, Inc

Carrie Bourdow
President & CEO, Trevena, Inc

Paul Brennan, Msc, Bsc
President & CEO, Nervgen Pharma

Aoife Brennan, Bao, Bch, Mrcpi
CEO and President, Synlogic

Ari Brettman
Managing Director, Blackstone Life Sciences

Christopher Burns
President And CEO, Venatorx Pharmaceuticals, Inc.

Benjamin Carpenter
Managing Director, Global Head of Life Sciences Mergers & Acquisitions, Citi

James Caruso
President, CEO & Director, Cellectar Biosciences, Inc.

Alan Cash
CEO, Metvital, Inc.

Daniel Chancellor
Therapeutic Area Director, Pharmaintelligence

Shomesh Chaudhuri
CTO, Qls Advisors

George Chen, MBA, MD
Chairman and CEO, D3 Bio

Lillian Chiang, Phd, Mba
CEO, Evrys

Will Chou
CEO, Aruvant Sciences, Inc.

Judy Chou, Phd
CEO and President, Altrubio, Inc.

Erick Co, Phd
Chief Executive Officer, Formosa Pharmaceuticals

Max Cynader
CEO, Primary Peptides Inc

Joseph Damond
Executive Vice President, International Affairs

Ulrich Dauer, Phd
CEO, Vivoryon Therapeutics

Jim DeMesa
President & Chief Executive Officer, Emerald Health Pharmaceuticals

David Dodd
Chairman, CEO, Geovax Labs, Inc

Douglas Doerfler
President & CEO, Maxcyte, Inc.

Denis Dufrane, Phd, Md
CEO & Founder, Novadip Biosciences Sa

Greg Duncan, MBA
Chairman and CEO, Virios Therapeutics

Mark Emalfarb
Chief Executive Officer, Dyadic International

Steven Engle
Chief Executive Officer, Cohbar Inc

Eric Falcand
VP Head of Business Development & Licensing, Servier

Robert Fallon
President & CEO, Phosplatin Therapeutics

Robert Foster
CEO, Hepion Pharmaceuticals, Inc

John Fowler
Chief Executive Officer, Kezar Life Sciences

Marisa Frackman
Managing Director, Capital Markets Advisory

Adena T. Friedman
President And Chief Executive Officer, Nasdaq, Inc.

Jeffrey Galvin
Chief Executive Officer, American Gene Technologies International Inc.

Bobby Gaspar, Phd, Md
Chief Executive Officer, Orchard Therapeutics Na

Julie Gerberding
Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, Merck

Albert Gianchetti
President & CEO, Xylocor Therapeutics

David Giljohann, Phd
CEO, Exicure, Inc.

Jessica Grossman, Md
CEO, Iggenix, Inc.

Kimberly Ha
CEO, KKH Advisors

Dror Harats, Md
Chief Executive Officer, Vascular Biogenics Ltd.

Michael Hay
General Manager, Informa, Clinical Success Rates And What Is Driving Them

Michael Hayden, Phd
CEO, Prilenia

Brian Heaphy
Vice President, Corporate Development, Cardiovascular & Neuroscience Business Development, Bristol Myers Squibb Company

Bill Hearl
President & CEO, Immunomic Therapeutics

Marc Hedrick, Md
President/CEO, Plus Therapeutics

Per Hellsund
PRESIDENT & CEO, Cybrexa Therapeutics

Sharon Hesterlee, Phd
Chief Research Officer, Muscular Dystrophy Association (MDA)

Zachary Hornby
CEO, Boundless Bio Inc.

Glenn Hunzinger
US Pharmaceutical and Life Sciences Leader, PWC

Patricia Hurter
CEO, Lyndra Therapeutics

Keith Ignotz, Mba
President & CEO, Ocumedic, Inc.

Pierre-Louis Joffrin
Corporate Development Officer, Mogrify Limited

Anthony Johnson
President/CEO, Kodikaz Therapeutic Solutions, Inc.

Troels Jordansen
Chairman/CEO, Glycostem Therapeutics

Alex Karnal
Partner, Deerfield Management Company LP

Anna Kazanchyan
Chief Executive Officer, Saghmos Therapeutics

Hans Keirstead
Chairman & CEO, Aivita Biomedical, Inc.

Lawrence Kenyon
President and CEO, Outlook Therapeutics, Inc.

Sunyoung Kim, Dphil
CEO, Helixmith Co., Ltd

Christopher Kirk
President & CSO, Kezar Life Sciences

Michael Kokesh
President & CEO, Vicardia Therapeutics, Inc.

Adam Koppel, Md, Phd
Managing Director, Life Sciences, Bain Capital

Ella Korets-smith, Mba, Msc
Chief Business Officer, Virica Biotech

Sara Lafever
Director, Research Support & Sagient Editorial

Pat Lawman
CEO, Morphogenesis Inc

Seth Lederman, Md
Chief Executive Officer, Tonix Pharmaceuticals

Luke Lee
CEO, Shaperon Inc.

Shawn Leland, Pharmd, Rph
Founder & CBO, Elevation Oncology

Rami Levin
President And Chief Executive Officer, Saniona

Matt Liddelow, Pharmd, Bsc
CEO & Managing Director, Neuroscientific Biopharmaceuticals Ltd

Bob Linke, Mba
CEO, Osmol Therapeutics, Inc

Casey Lippmeier
VP, Research And Development, Conagen

Roy Lipski
CEO, Creo Ingredients

Yue Liu, Phd
President, Ab Studio Inc

Andrew Luber
President & Chief Executive Officer, Virion Therapeutics

Maria Maccecchini, Phd
President & CEO, Annovis Bio, Inc

Brad Margus
CEO, Cerevance

Tyler Martin, MD
CEO, Adjuvance Technologies, Inc.

Sabrina Martucci Johnson
President & CEO, Daré Bioscience

Glenn Mattes
President, Chief Executive Officer And Director, Tff Pharmaceuticals

John Maxwell
CFO, Aquestive Therapeutics

David Mazzo, Phd
President & CEO, Caladrius Biosciences

Michelle Mcmurry-heath, Md, Phd
President And CEO, Biotechnology Innovation Organization, Biotech's Finest Hour: A Discussion On Corporate Leadership And Equity

Orly Mishan
Chief Business Officer, Cerevel

James Moe
President, Oligomerix

Timothy Morris
COO/CFO, Humanigen

Shankar Musunuri, Phd, Mba
Chief Executive Officer, Ocugen

Carolyn Ng
Managing Director, Vertex Ventures

Daniel O'connor, Jd
President & CEO, Oncosec Immunotherapies

Kay Olmstead
CEO, Nano Pharmasolutions, Inc

John Oyler
Senior Vice Founder and CEO, Beigene

Carlo Passeri
Director, Capital Markets & Financial Services Policy, Biotechnology Innovation Organization

Snehal Patel
Chief Executive Officer, Greenwich Lifesciences

Joseph Payne, Msc
Founder, President & CEO, Arcturus Therapeutics

Adelene Perkins
Chair & Chief Executive Officer, Infinity Pharmaceuticals, Inc.

Richard Pops
Chairman & CEO, Alkermes, Inc.

Steven Potts, Phd, Mba
Founder And CEO, Oncomyx Therapeutics

David Pyrce
CEO, Devacell, Inc.

Spiro Rombotis, Mba, Mph
President & CEO, Cyclacel Pharmaceuticals

John Ramunas
CEO, Rejuvenation Technologies Inc.

Deborah Rathjen, Phd
Executive Chair, Bioasis Technologies, Inc.

Thomas Reeves
President & CEO, Ripple Therapeutics Corporation

Spiro Rombotis, Mba, Mph
President & CEO, Cyclacel Pharmaceuticals, Inc

Amanda Rose
Partner, Fenwick & West Llp

Susan Ruediger
CEO, Charcot-marie-tooth Research Foundation

Stephen Russell, Phd, Md
President & CEO, Vyriad, Inc.

Alif Saleh
CEO, Scipher Medicine

Mark Sampson, MD
CEO, Circadian Therapeutics

James Sapirstein, Mba, Rph
Chief Executive Officer, Azurrx Biopharma Inc.

Oscar Segurado, Md, Phd
CMO, Asc Therapeutics, Inc.

Kunwar Shailubhai
CEO/CSO, Tiziana Life Sciences

Steven Shallcross, MBA, CPA
CEO & CFO, Synthetic Biologics, Inc

Sanjay Shukla, Md, Ms
President, CEO, Atyr Pharma, Inc.

Rahul Singhvi
Chief Executive Officer, National Resilience Inc.

Mark Sirgo, Pharmd
Chief Executive Officer, Aruna Bio

David Slack
President & CEO, Cend Therapeutics Inc.

Yochi Slonim
Co-founder and CEO, Anima Biotech Inc.

Caroline Stark Beer
Chief Business Officer, Jnana Therapeutics

Lisa Stehno-bittel, Phd
President & Founder, Likarda, Llc

Subree Subramanian, MS, PhD
CSO, EV Therapeutics, Inc.

Marco Taglietti, MD
President & Chief Executive Officer, Scynexis, Inc.

John Temperato
President & CEO, 9 Meters Biopharma, Inc.

David Thomas
Vice President, Industry Research, Biotechnology Innovation Organization

Pascal Touchon
President & CEO, Atara Biotherapeutics

Hasan Uludag
President, RJH Biosciences Inc

Dan Vickery
CEO, Urigen Pharmaceuticals, Inc

Francois Vigneault, PHD
President and CEO, Shape Therapeutics, Inc.

Stefan Weber
CEO, Managing Director, Newron Pharmaceuticals, Spa

Martin Welschof, Phd
CEO, Bioinvent International Ab

Russell Wilson
Acting Chief Executive Officer and Chief Scientific Officer, Stadius Biopharma Llc

Blake Wise
Chief Executive Officer, Novome Biotechnologies, Inc.

Adam Woodrow
President & Chief Commercial Officer, Paratek Pharmaceuticals, Inc

Guo-liang Yu, Phd
Chief Executive Officer, Apollomics, Inc.

Lihua Zheng, Phd, Jd
Founder and CBO, Anheart Therapeutics (Hangzhou) Co., Ltd.

Michael Zhou
Chief Medical Scientist, Ascent Innovation

Sponsors & Partners

2021 Sponsors and Partners

• Lilly
• Avantor
• Nuventra
• ROTH Capital Partners
• Scendea
• Share Vault

• 3E Bioventures
• 3T Biosciences
• 3Z Pharmaceuticals
• 9 Meters Biopharma, Inc.
• Ab Studio Inc.
• Actinium Pharmaceuticals, Inc
• Acuitas Capital, LLC_Marc Heal
• Acuris Partners
• Adastra Pharmaceuticals
• Adjuvance Technologies Inc.
• Adjuvant Capital
• AffyImmune Therapeutics, Inc.
• Agastiya Biotech
• Agent Capital
• Agilent Technologies, Inc
• AIG Global Investment Corporation
• Aisling Capital LLC
• AiVita Biomedical, Inc.
• Alliance for Aging Research
• Alliance for Cancer Gene Therapy Foundation
• AltruBio, Inc.
• Altus Investment
• Alykomed Global Solutions LLC
• American Gene Technologies International Inc.
• Amplitude Ventures
• AnHeart Therapeutics Inc.
• Anima Biotech Inc.
• Annovis Bio, Inc.
• Antabio
• Anzu Partners
• Apollomics, Inc.
• Aquestive Therapeutics, Inc.
• Arch Venture Partners
• Arcturus Therapeutics
• Arix Bioscience
• ArunA Bio
• Aruvant Sciences, Inc.
• ASC Therapeutics
• Atara Biotherapeutics
• ATEM Capital
• ATEM Capital_Elena Malic
• aTyr Pharma, Inc.
• Avery Therapeutics, Inc.
• Avilex Pharma
• AzurRx BioPharma Inc.
• Baudax Bio
• Bellerophon Therapeutics
• Bellevue Asset Management
• Berlin Partner GmbH
• Beyond Next Ventures
• BeyondBio Inc
• BIMA Capital, LLC
• Bioasis Technologies, Inc.
• BioIdeations
• Bioincept, Llc
• BioInvent International AB
• Bios Partners
• Biotechnology Innovation Organization
• Bioversys AG
• Boundless Bio Inc.
• BTIG, LLC_Bert Hazlett
• Caladrius Biosciences, Inc
• California Life Sciences Association
• Canica Holding AG
• CBC Group
• Cellectar Biosciences, Inc.
• Cend Therapeutics Inc.
• Cerevance, Inc.
• Chaperone Investment
• Chardan Capital Markets
• ChemomAb
• Chronon Capital
• Circadian Therapeutics
• Clarametyx Biosciences
• CLI Ventures
• CMT Research Foundation
• CohBar Inc.
• Conagen, Inc
• Cottonseed Capital
• Cowen Healthcare Investments
• Crawford Lake Capital
• Cross Current Research LLC
• Crosswave Management
• Curam Capital Management LLP
• Curemeta
• Cyclacel Pharmaceuticals, Inc
• Cytori Therapeutics, Inc
• D3 Bio
• Dalton Investment
• Daré Bioscience
• DRI Capital, Inc
• Drusolv Therapeutics
• Dyadic International, Inc
• Dynamk Capital
• EA Pharma Co., Ltd.
• efficacyAI, Inc.
• Eisai Co., Ltd. / Corporate Venture Investment
• Emerald Health Sciences
• Engrail Therapeutics, Inc.
• Enterin
• Equillium, Inc.
• Erytech Pharma
• EV Therapeutics, Inc.
• Evrys Bio
• Exicure, Inc.
• Exopharm Ltd
• Fast Track Initiative
• Feldan Therapeutics
• First Seafront Fund Management
• Flanders Investment & Trade
• FMG Ventures
• Formosa Pharmaceuticals
• Fortunatus Capital
• Gateway Biotechnology Inc.
• Genekam Biotechnology AG
• Generation Fund
• Genesis Pharma S.A
• GeoVax Labs, Inc
• Global Emerging Markets (GEM) Group
• Global Neurohealth Ventures
• Glycostem Therapeutics
• Good Health Capital
• Great Bay Bio Limited
• Greater Zurich Area
• Greenwich LifeSciences
• H.C. Wainwright & Company_Analysts
• H.C. Wainwright & Company_Ed Arce
• H.C. Wainwright & Company_Michael King
• H.C. Wainwright & Company_Yi Chen
• HanaVax Inc.
• HaplnScience Inc.
• Harbor Street Ventures
• Hayan Health Networks
• Health Innovative Technology Corporation
• Healthcare Capital LLC
• HealthCare Royalty Partners_Amogh Sivarapatna
• HealthCare Royalty Partners_Anthony Rapsomanikis
• HealthCare Royalty Partners_Matt Bullard
• HEDA Ventures
• Helixmith Co., Ltd
• Hepion Pharmaceuticals, Inc.
• Hestia Investments Ltd.
• Holy Stone Healthcare Co., Ltd.
• Humanigen, Inc.
• Ichor Biologics
• IgGenix, Inc.
• Igia Pharmaceuticals
• Ignite Capital Partners, Inc.
• Illumina Accelerator
• illumina Ventures
• Image Analysis Group
• Imagiance LLC
• Imbrium Therapeutics
• Immunomic Therapeutics, Inc
• Individual Investor_Stella Kwek
• Inflection Biosciences Ltd
• Intec Pharma Ltd
• Intuitive
• InvivoSciences, Inc.
• Iovance Biotherapeutics
• IPF Partners
• Jafco Co., Ltd.
• JEG Capital Partners LLC
• Jina Ventures
• Johnston Associates Inc.
• Kalka Fund
• Keystone Capital Partners
• Kezar Life Sciences
• Kisoji Biotechnology
• Kitov Pharma Ltd.
• Kodikaz Therapeutic Solutions, Inc
• Krensavage Asset Management LLC
• Kyto Technology and Life Science
• Lactocore, Inc.
• Ladenburg Thalmann
• Lead Pharma
• Lempo Therapeutics Ltd.
• LEO Pharma (LEO I lab ventures)
• Leukosbiotech SL
• Life Science Angels, Inc_Friedhelm Blobel
• Lifespan Investments
• Likarda, LLC
• Livingston LLC
• Locust Walk
• Loki Therapeutics
• LQT Therapeutics Inc.
• Lumira Ventures
• Lyndra
• MaxCyte, Inc
• MediVentures GmbH
• Meyer Associates, L.p.
• Mira Life Science Ventures
• Mitsui & Co. Global Investment Inc.
• Mizuho Securities
• Mogrify Limited
• Momentum Biotech
• MSQ Ventures
• Muscular Dystrophy Association (MDA)
• MVM Life Science Partners LLP
• MVP Capital Partners
• Myeloma Investment Fund
• Nan Fung Life Sciences
• Nano PharmaSolutions, Inc.
• NanoView Biosciences
• Negma Group
• NervGen Pharma
• Neumentum, Inc.
• Neuroscientific Biopharmaceuticals Ltd
• Neurotez, Inc
• New Enterprise Associates (NEA)
• New Grounds Venture Capital
• Newron Pharmaceuticals, SpA
• Nivagen Pharmaceuticals Inc.
• Notable Labs
• Novadip Biosciences SA
• NovaQuest Capital Management
• Novo Ventures
• Novome Biotechnologies, Inc.
• Ocugen
• OcuMedic, Inc.
• Oligomerix, Inc.
• OncoMyx Therapeutics
• OncoSec Immunotherapies
• OniX Hub & Ventures
• Orange Grove Bio
• Orchard Therapeutics NA
• Osmol Therapeutics, Inc.
• Oxford Finance LLC
• Panacea Venture Healthcare
• Panacea Venture Healthcare_Benjamin Chen
• Panakes
• Paras Biopharmaceuticals Finland Oy
• Paratek Pharmaceuticals, Inc
• Parkinson's UK
• Parnell Pharmaceuticals, Inc.
• Perseverance Capital
• PharmaDirections, Inc.
• Pharmstandard Ventures
• Phosplatin Therapeutics LLC
• Pontifax
• Pontifax_Ohad Hammer
• Prellis Biologics
• Prevail Partners
• Prilenia
• Primary Peptides Inc
• Prime Movers Lab
• Protalix Biotherapeutics Inc.
• Purohit Ventures
• Qiming Venture Partners
• Ragu Investment Group
• Red Tree Venture Capital
• Rejuvenation Technologies Inc.
• Remiges Ventures
• Resilience Therapeutics Inc
• Rev1 Ventures
• Ripple Therapeutics
• Saghmos Therapeutics
• Saisei Ventures
• Salubris Biotherapeutics Inc.
• Saniona
• Santen Pharmaceutical Co., Ltd.
• SarcomedUSA, Inc.
• Sarissa Capital Management
• Satter Medical Technology Partnership
• Scendea Ltd
• Scipher Medicine
• Scynexis, Inc.
• SeaX Ventures
• Servier
• SFA Therapeutics, LLC
• Shape Therapeutics, Inc.
• Shaperon Inc.
• ShareVault
• Signature Bank
• Sinar Mas Technology
• Sofinnova Ventures
• Solasta Ventures
• Soricimed Biopharma Inc.
• SOUSEIKAI Global Clinical Research Center
• Springcamp
• Stadius BioPharma
• Stingray Therapeutics
• Strathspey Crown
• Sun Genomics
• Swiss Business Hub USA
• Synlogic
• Synthetic Biologics, Inc
• Taiho Ventures, LLC
• Taiho Ventures, LLC_Takaaki Ishii
• Tallc Inc.
• TargetGene Biotechnologies
• Tectonic Capital
• Tenax Therapeutics, Inc.
• TFF Pharma
• The Benchmark Company
• The Biocollective, Llc
• The Leukemia & Lymphoma Society
• Tiziana Life Sciences
• TONIX Pharmaceuticals
• Topadur Pharma AG
• Toray Industries
• Trevena, Inc
• TVM Life Science Inc.
• Unicorn Capital Partners
• V2m Life Sciences Fund
• VBL Therapeutics
• Venatorx Pharmaceuticals
• Venrock
• VentureEdge LLC
• Versantis
• ViCardia Therapeutics, Inc.
• Vincerx Pharma
• Virica Biotech
• Virion Therapeutics
• Viva BioInnovator
• Vivoryon Therapeutics N.V.
• Vyriad, Inc.
• WARF Therapeutics
• WI Harper
• Willow Advisors LLC
• X-Therma Inc.
• Xeraya Capital Life Venture
• Yunion Healthcare Ventures